⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 24 in last 7 days 🍎 Food: 211 in last 7 days 🧸 Products: 73 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 25 minutes ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 24 in last 7 days 🍎 Food: 211 in last 7 days 🧸 Products: 73 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 25 minutes ago
🛡️ EUSW
🇬🇧
🍎 Food NL FR DE April 11, 2023

1,3-DMBA - 1,4 DMAA and yohimbine in food supplement from United Kingdom

Classification
Alert notification
Risk
Serious
Category
dietetic foods, food supplements and fortified foods
Hazard
1,3-dimethylamylamine (DMAA) unauthorised - {composition} *** 1,3-dimethylbutylamine (nor- DMAA) unauthorised substance - {composition} *** yohimbine
Origin
United Kingdom
Notifier
Netherlands
🗄
Archived (older alert)
This alert was reported 1145 days ago and has been moved from our active feed to the archive. The original safety information still applies — we have no confirmation from the issuing agency that the product is safe again. Refer to the official notice for the current status.
📈 Timeline
0 days in total
May 17, 2026 May 17, 2026
Daily snapshot data starts accumulating once the scheduler runs — for now this is interpolated from the agency's first/last dates.

What is this? A food supplement from the United Kingdom may contain three stimulants: 1,3-DMBA, 1,4-DMAA, and yohimbine. These are not allowed in food supplements in the EU.

What's happening? The supplement has been recalled in the Netherlands, France, and Germany because it contains these banned stimulants.

Does this affect me? If you bought this supplement in the UK or in the Netherlands, France, or Germany, it may affect you.

What should I do? Stop using the supplement and ask your pharmacist or doctor for advice.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Agency-published detail

Classification: Alert notification · Risk: Serious · Category: dietetic foods, food supplements and fortified foods · Hazard: 1,3-dimethylamylamine (DMAA) unauthorised - {composition} *** 1,3-dimethylbutylamine (nor- DMAA) unauthorised substance - {composition} *** yohimbine · Origin: United Kingdom · Notifier: Netherlands

First published
April 11, 2023
Last refreshed by us
1 week ago
Severity (as classified)
High
Official source
https://webgate.ec.europa.eu/rasff-window/screen/search?notificationReference=2023.2436

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

❓ Frequently asked questions

What is this product recall alert about?
1,3-DMBA - 1,4 DMAA and yohimbine in food supplement from United Kingdom. Classification: Alert notification · Risk: Serious · Category: dietetic foods, food supplements and fortified foods · Hazard: 1,3-dimethylamylamine (DMAA) unauthorised - {composition} *** 1,3-dimethylbutylamine (nor- DMAA) unauthorised substance - {composition} *** yohimbine · O...
When was this alert issued?
This alert was issued on April 11, 2023 by EU RASFF.
Which countries are affected?
The alert applies to the following countries: Netherlands, France, and Germany.
How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
What should I do?
If you have this product at home, stop using it and return it to the point of purchase for a refund. Keep the receipt if you have one — most retailers refund without it for safety recalls.
Where can I find the official notice?
The full official notice is published on webgate.ec.europa.eu.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.